GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (LTS:0RD1) » Definitions » Purchase Of Investment

Camurus AB (LTS:0RD1) Purchase Of Investment : kr0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Camurus AB Purchase Of Investment?

Camurus AB's purchase of investment for the three months ended in Mar. 2025 was kr0 Mil. It means Camurus AB spent kr0 Mil on purchasing investments. Camurus AB's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was kr0 Mil.

Compared with last quarter (kr0 Mil in Dec. 2024 ), Camurus AB spent the same money on purchasing investments in Mar. 2025 (kr0 Mil).

Camurus AB Purchase Of Investment Historical Data

The historical data trend for Camurus AB's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Purchase Of Investment Chart

Camurus AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Camurus AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Camurus AB Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camurus AB Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Camurus AB's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Camurus AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (LTS:0RD1) » Definitions » Purchase Of Investment
Comparable Companies
OSTO:BIOA B OSTO:FLERIE OSTO:BINV OSTO:HNSA OSTO:VICO OSTO:GENO OSTO:EGTX OSTO:XSPRAY OSTO:SANION OSTO:SYNACT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
CAMRF:USA CAMX:Sweden CAMXs:UK 7CA:Germany
Address
Ideon Science Park, Lund, SWE, SE-223 70
Website
https://www.camurus.com
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

No Headlines